• Willing and able to give informed consent and follow all study procedures and requirements.
• Healthy male or nonpregnant female, ages 6518 to <60 years.
• Body mass index (BMI) 6518.5 to <35 kg/m2; weight 6555 kg at Screening.
• Absence of important health problems and essentially normal physical examination, normal laboratory screening tests, and normal electrocardiogram (ECG) with QTc interval corrected for heart rate using the Fridericia method (QTcF) 65450 ms.

• Evidence of clinically significant abnormalities or disease.
• Unless permitted by protocol, use of any prescription medication 654 weeks or investigational medication 6512 weeks or 655 half-lives (whichever is longer) of dosing.
• Use of any non-prescription medication or herbal/nutritional supplement 655 days prior to dosing.
• Donation or loss of > 1 unit (450 mL) of blood 651 month prior to dosing.
• Females: nursing, lactating, or pregnant.
• Females: breast implants.
• Use of nicotine-containing products in the last 6 months prior to dosing.
• History of substance abuse or dependency or history of recreational drug use within the last 2 years.
• Alcohol consumption > 14 drinks per week for males (7 for females) within 45 days of screening.
• Positive screen for drugs of abuse or alcohol or nicotine exposure test at Screening or Admission.

Additional protocol defined inclusion/exclusion criteria may apply.